1. 2020
  2. Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33

    Romão, E., Krasniqi, A., Maes, L., Vandenbrande, C., Sterckx, Y. G-J., Stijlemans, B., Vincke, C., Devoogdt, N. & Muyldermans, S., 2 Jan 2020, In : International Journal of Molecular Sciences. 21, 1, 310.

    Research output: Contribution to journalArticle

  3. Reshaping nanobodies for affinity purification on protein a

    Crauwels, M., Van Vaerenbergh, N., Kulaya, N. B., Vincke, C., D'Huyvetter, M., Devoogdt, N., Muyldermans, S. & Xavier, C., 2020, In : New Biotechnology. 57, p. 20-28 9 p.

    Research output: Contribution to journalArticle

  4. 2019
  5. An innovative approach in the detection of Toxocara canis excretory/secretory antigens using specific nanobodies

    Morales-Yanez, F. J., Sariego, I., Vincke, C., Hassanzadeh-Ghassabeh, G., Polman, K. & Muyldermans, S., Jul 2019, In : International Journal for Parasitology. 49, 8, p. 635-645 11 p.

    Research output: Contribution to journalArticle

  6. 2018
  7. The development and validation of a novel Nanobody-Based competitive ELISA for the detection of foot and mouth disease 3ABC antibodies in cattle

    Gelkop, S., Sobarzo, A., Brangel, P., Vincke, C., Estevens Romão, E., Fedida-Metula, S., Strom, N., Ataliba, I., Mwiine, F. N., Ochwo, S., Velazquez-Salinas, L., Mc Kendry, R. A., Muyldermans, S., Lutwama, J. J., Rieder, E., Yavelsky, V. & Lobel, L., 12 Oct 2018, In : Frontiers in Veterinary Science. 5, OCT, p. 250 250.

    Research output: Contribution to journalArticle

  8. Combinatorial design of a nanobody that specifically targets structured RNAs

    Cawez, F., Duray, E., Hu, Y., Vandenameele, J., Estevens Romão, E., Vincke, C., Dumoulin, M., Galleni, M., Muyldermans, S. & Vandevenne, M., 25 May 2018, In : J Mol Biol. 430, 11, p. 1652-1670 19 p.

    Research output: Contribution to journalArticle

  9. Construction of High-Quality Camel Immune Antibody Libraries

    Romão, E., Poignavent, V., Vincke, C., Ritzenthaler, C., Muyldermans, S. & Monsion, B., 2018, In : Methods in Molecular Biology. 1701, p. 169-187 19 p.

    Research output: Contribution to journalArticle

  10. Nanobodies against EGFblocking the oncogenic activation of EGFR

    Guardiola, S., Varese, M., Sanchez-Navarro, M., Vincke, C., Teixido, M., Garcia, J., Muyldermans, S. & Giralt, E., 2018, In : Angewandte Chemie. 57, 42, p. 13843-13847

    Research output: Contribution to journalArticle

  11. 2017
  12. Inhibiting the Ca 2+ Influx Induced by Human CSF

    Drews, A., De, S., Flagmeier, P., Wirthensohn, D. C., Chen, W-H., Whiten, D. R., Rodrigues, M., Vincke, C., Muyldermans, S., Paterson, R. W., Slattery, C. F., Fox, N. C., Schott, J. M., Zetterberg, H., Dobson, C. M., Gandhi, S. & Klenerman, D., 12 Dec 2017, In : Cell Reports. 21, 11, p. 3310-3316 7 p.

    Research output: Contribution to journalArticle

  13. Innovative bioconjugation methods for an improved detection of ovarian cancer at early stage using multiple biomarkers

    Tran, H., Smiejkowska, N. W., Vincke, C., Devoogdt, N., Muyldermans, S., Adriaensens, P. & Guedens, W., 27 Sep 2017.

    Research output: Unpublished contribution to conferencePoster

  14. Exploiting sequence and stability information for directing nanobody stability engineering

    Kunz, P., Flock, T., Soler, N., Zaiss, M., Vincke, C., Sterckx, Y., Kastelic, D., Muyldermans, S. & Hoheisel, J. D., Sep 2017, In : BBA General Subjects. 1861, 9, p. 2196-2205 10 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 Next

ID: 104479